La Pediatria di Netter – Sezione 20 – Antonio Delfino Editore

Jessica Perfetto, and Pamela F. Weiss

Giancane G, Alongi A, Ravelli A. Update on the pathogenesis and treatment of juvenile idiopathic arthritis. Curr Opin Rheumatol . 2017;29(5):523–529.
Giancane G, et al. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther . 2016;3(2):187–207.
Mahmud S.A, Binstadt B.A. Autoantibodies in the pathogenesis, diagnosis, and prognosis of juvenile idiopathic arthritis. Front Immunol . 2018;9:3168.
Palman J., et al. Update on the epidemiology, risk factors and disease outcomes of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol. 2018;32(2):206–222.
Ravelli A, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis . 2018;77(6):819–828.

Adam S. Mayer, and Pamela F. Weiss

Lundberg IE, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol . 2017;69(12):2271–2282.
Oddis CV, et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheumatol . 2013;65(2):314–324.
Pachman LM, Khojah AM. Advances in juvenile dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity. J Pediatr . 2018;195:16–27.

Roberto Alejandro Valdovinos, and Pamela F. Weiss

Ahmed M., Moreira A, Acosta S, et al. Multisystem Inflammatory Syndrome in Children: A Systematic Review. EClinicalMedicine; 2020.
Cabral D, Morishita K. Vasculitis in children: evaluation overview. UpToDate. May 15 . 2019.
de Graeff N., Groot N, Brogan P, et al.. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative. Rheumatology. 2019;58(4):656–671.
Diorio C., Henrickson SE, Vella LA, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020;130(11):5967–5975.
Henderson L.A., Canna S.W.Friedman KG, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS‐CoV‐2 and Hyperinflammation in Pediatric COVID‐19: version 1. Arthritis Rheumatol; 2020;72(11):1791–1805.
Oni L, Sumpath S. Childhood IgA vasculitis (Henoch Schonlein Purpura) – advances and knowledge gaps. Front Pediatr . 2019;7:257.

Roberto Alejandro Valdovinos, and Pamela F. Weiss

Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun . 2019;96:1–13.
Harry O, Yasin S, Brunner H. Childhood-onset systemic lupus erythematosus: a review and update. J Pediatr . 2018;196:22–30.
Mina R, Brunner H.I. Pediatric lupus – are there differences in presentation, genetics, response to therapy, damage accrual compared to adult lupus? Rheum Dis Clin North Am . 2010;36(1):53–80.

Sarah E. Capponi, and Pamela F. Weiss

Sarcoidosis

Caso F, Costa L, Rigante D, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev . 2014;13(23):1220–1229.
Ianuzzi M.C, Rybicki B.A, Teirstein A.S. Sarcoidosis. N Engl J Med . 2007;357:2153–2165.
Shetty A.K, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J . 2008;6:16–25.

Granulomatosis With Polyangiitis

Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr . 2004;163:425–434.
James K.E, Xiao R, Merkel P.A, Weiss P.F. Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis. Clin Exp Rheumatol . 2017;35(1 suppl 103):202–208.
Jariwala MP, Laxer RM. Primary vasculitis in childhood: GPA and MPA in childhood. Front Pediatr . 2018;6:226. doi: 10.3389/fped.2018.00226.
O’Neil K.M. Progress in pediatric vasculitis. Curr Opin Rheumatol . 2009;21(5):538–546.

Eosinophilic Granulomatosis With Polyangiitis

Fina A, et al. Eosinophilic granulomatosis with polyangiitis in children: data from the French RespiRare® Cohort. Pediatr Pulmonol . 2018;53(12):1640–1650. doi: 10.1002/ppul.24089.

Familial Juvenile Systemic Granulomatosis (Blau Syndrome)

Wouters CH, et al. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J . 2014;12 doi: 10.1186/1546-0096-12-33.

Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD)

Verbsky JW, Routes JM. Sarcoidosis and common variable immunodeficiency: similarities and differences. Semin Respir Crit Care Med . 2014;35(3):330–335. doi: 10.1055/s-0034-1376862.